| Literature DB >> 34118230 |
Patrick Jones1, Karin M Hjelle2, Jannike Mohn3, Gigja Guðbrandsdottir2, Ingunn Roth3, Adeel Asghar Chaudhry3, Anne Kvåle Bergesen3, Christian Beisland2.
Abstract
Bladder pain syndrome (BPS) is a complex condition, which can have debilitating sequelae for patients. Many elements of BPS remain poorly understood including pathophysiology, diagnosis and treatment. Navigating patient care can therefore be challenging for the clinician. Management mandates a multidisciplinary and symptom-based approach. Intravesical treatments such as instillation therapies remain a cornerstone of most treatment algorithms and there are a range of agents that can be selected. This review offers an up-to-date evaluation of the evidence for these intravesical treatments.Entities:
Mesh:
Year: 2021 PMID: 34118230 DOI: 10.1016/j.urology.2021.05.042
Source DB: PubMed Journal: Urology ISSN: 0090-4295 Impact factor: 2.649